Bevacizumab 1 recalled over sterility concerns
- Recall date
- October 2, 2023
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Pine Pharmaceuticals, LLC recalls Bevacizumab 1.25 MG/0.05 ML Solution for Injection, 1 mL syringes, Rx only, Compounded by Pine Pharmaceuticals 355 Rive…
- Recall number
- D-0050-2024
- FDA classification
- Class II
- Brand / firm
- Pine Pharmaceuticals, LLC
- Sold / distributed
- Nationwide within the United States
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Bevacizumab 1.25 MG/0.05 ML Solution for Injection, 1 mL syringes, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
Get recall alerts
Free email alert whenever Pine Pharmaceuticals, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Pine Pharmaceuticals, LLC